- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Price disconnect
Taiwanese Pharmaceuticals & Biotech Price disconnect
Results
7
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
7 companies
TTY Biopharm
Market Cap: NT$18.6b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.
4105
NT$76.60
7D
0.3%
1Y
-1.0%
Standard Chemical & Pharmaceutical
Market Cap: NT$11.2b
Manufactures and sells pharmaceutical products in Taiwan and internationally.
1720
NT$56.30
7D
-1.7%
1Y
6.4%
Cenra
Market Cap: NT$4.7b
Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.
3716
NT$32.20
7D
-2.6%
1Y
-6.4%
Allied Biotech
Market Cap: NT$2.3b
Engages in the manufacture and sale of carotenoids worldwide.
1780
NT$23.45
7D
-2.9%
1Y
32.1%
TSH Biopharm
Market Cap: NT$1.9b
Develops and markets pharmaceutical products in Taiwan.
8432
NT$50.30
7D
0.6%
1Y
4.1%
Taiwan Advance Bio-Pharmaceutical
Market Cap: NT$799.2m
Operates in the biotechnology industry in China, Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
4186
NT$8.92
7D
-2.4%
1Y
-13.0%
Bioray Biotech
Market Cap: NT$553.2m
Engages in the research, development, production, and sells health foods, immune cell products, and precision testing services in Taiwan.
7561
NT$18.70
7D
-3.9%
1Y
-24.3%